Biogen
BIIB
#647
Rank
$29.60 B
Marketcap
$198.18
Share price
-2.70%
Change (1 day)
-30.66%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : $12.04 B

According to Biogen's latest financial reports the company's total liabilities are $12.04 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Biogen - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31$12.04 B7.88%
2022-12-31$11.16 B-13.56%
2021-12-31$12.91 B-7.29%
2020-12-31$13.93 B0.27%
2019-12-31$13.89 B13.36%
2018-12-31$12.25 B10.88%
2017-12-31$11.05 B2.85%
2016-12-31$10.74 B6.1%
2015-12-31$10.12 B189.37%
2014-12-31$3.50 B7.96%
2013-12-31$3.24 B2.41%
2012-12-31$3.16 B20.73%
2011-12-31$2.62 B-0.77%
2010-12-31$2.64 B15.42%
2009-12-31$2.28 B-13.42%
2008-12-31$2.64 B-14.53%
2007-12-31$3.09 B120.56%
2006-12-31$1.40 B-4.93%
2005-12-31$1.47 B-36.91%
2004-12-31$2.33 B-4.54%
2003-12-31$2.45 B157.96%
2002-12-31$0.94 B155.23%
2001-12-31$0.37 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$98.78 B 720.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$137.21 B 1,039.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$124.31 B 932.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$90.92 B 654.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.61 B 378.30%๐Ÿ‡ซ๐Ÿ‡ท France
$39.37 B 226.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.36 B-63.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.30 B-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.30 B-80.84%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$3.55 B-70.46%๐Ÿ‡บ๐Ÿ‡ธ USA